.png){kind=icon}
.png){kind=icon}
Return
The TPx Protein of Cysticercus cellulosae Promotes an IL-10–Producing Regulatory B Cell Phenotype in Human B Lymphoblastoid Cells via the cAMP/CREB Pathway
.png){kind=icon}
OA
AI
H
X
H
Q
B
DOI：10.3390/cells15161429.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Thioredoxin peroxidase (TPx) derived from Taenia solium cysticerci (Cysticercus cellulosae) mediates immune evasion by disrupting T cell subset homeostasis. However, its effect on regulatory B cells (Bregs) and the underlying mechanism remain unknown. We stimulated GM12878 B cells with TPx and assessed Breg differentiation by flow cytometry, ELISA, and RT-qPCR. We evaluated the function of TPx-pretreated B cells in co-culture with T cells. We then combined RNA sequencing, Western blot, ELISA, and pharmacological inhibition to identify the signaling pathway involved. TPx increased the CD19+CD24hiCD27+ Breg subset in a time-dependent manner, peaking at 72 h. This effect was accompanied by enhanced IL-10 secretion and upregulated transcription of IL-10, TGF-β, and IL-35. TPx-pretreated B cells reduced CD4+ T-cell blastogenesis (cell size) and the CD4+ fraction of the co-culture and increased the frequency of cells with a CD4+CD25+CD127− Treg-like surface phenotype. RNA sequencing identified cAMP-related pathways as central to this process. TPx elevated intracellular cAMP and activated the PKA/CREB phosphorylation cascade, whereas the adenylyl cyclase inhibitor SQ22536 reversed TPx-induced Breg differentiation and IL-10 secretion. In this human B cell line model, TPx promotes acquisition of a Breg-like phenotype in an adenylyl cyclase–dependent manner, revealing a novel mechanism of cysticercosis-associated immune evasion.
Keywords:
<i>Taenia solium</i>
<i>Cysticercus cellulosae</i>
thioredoxin peroxidase
cAMP/CREB signaling pathway
Breg cell differentiatio
Journal
IF:
5.2
Papers:
2.1W
Citations:
9.4W
Organization
Cited Papers